Article

ARVO/Alcon early career clinician-scientist research award winners announced

The ARVO Foundation for Eye Research, a supporting non-profit of The Association for Research in Vision and Ophthalmology (ARVO), announced the recipients of the 2007 ARVO/Alcon early career clinician-scientist research awards.

The ARVO Foundation for Eye Research, a supporting non-profit of The Association for Research in Vision and Ophthalmology (ARVO), announced the recipients of the 2007 ARVO/Alcon early career clinician-scientist research awards.

Designed to recognize the importance of clinician-scientists in the ophthalmic research community, the awards are given based on the quality of each recipient's research presented at the ARVO annual meeting. The awardees, who receive grants of $3,000 each, are clinicians with an academic faculty or comparable appointment committed to a career with protected research time. They also work or have previously worked under the guidance of a mentor.

This year's recipients and the abstracts on which the awards are based are:

  • Nitza Goldenberg-Cohen, MD, Schneider Children's Medical Center, Shoham, Israel, "Enhanced neuronal differentiation of bone marrow-derived stem cells in ischemic retina."


  • Andras M. Komaromy, DVM, PhD, University of Pennsylvania School of Veterinary Medicine, Philadelphia, "Cone-directed gene therapy with rAAV leads to restoration of cone function in a canine model of achromatopsia."


  • Rainer A. Leitgeb, PhD, Ecole Polytechnique Federale, Lausanne, Switzerland, "Macular pigment optical density, serum C-reactive protein, and serum lutein and zeaxanthin in age-related maculopathy (ARM)."


  • Malin Malmsjo, MD, PhD, Lund University, Sweden, "Retinal ischemia reperfusion: a new animal model suitable for experimental analysis of the retinal arteries."


  • Takahiro Suzuki, MD, PhD, Tokai University School of Medicine, Ishehara, Japan, "Improvement of pathological neovascularization and astrocyte abnormalities in a mouse model of oxygen-induced retinopathy by augmenting bone marrow-derived endothelial progenitor cell recruitment via link deletion."

Funded by a donation to the foundation from Alcon Laboratories, the awards were presented Sunday during the ARVO/Alcon keynote session.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.